Gerilyn M. Olsen, BA; Leanna M. Hansen, BS; Nicole S. Stefanko, MD; et al.
This cohort study assesses the incidence of adverse events among patients with PHACE (posterior fossa malformations, hemangioma, arterial anomalies, cardiac defects, eye anomalies) syndrome receiving oral propranolol for infantile hemangioma.